C 18 H 17 FeN 3 O 2 S, triclinic, P1 (no. 2), a =7.8088(2) Å, b =10.5763(3) Å, c =11.9799(3) Å, a =109.277(1)°, b =107.856(1)°, g =97.832(1)°, V =857.3 Å 3 , Z =2,
Source of material
All reagentsa nd solvents were purchased from commercial sourcesa nd used as received. The title compound is obtained from as erieso fr eactions involving the synthesis of 2-ethyl-1-ferrocenylsulfonyl-1H-imidazo [4,5-b] pyridine from 2-ethyl-1H-imidazo [4,5-b] pyridine and ferrocenylsulfonylc hloride. A solution of 2-ethyl-1H-imidazo [4,5-b] pyridine (0.4 g, 2.7mmol) in acetonitrile (18 mL) was added to am ixture of ferrocenylsulfonylchloride (0.72 g, 2.5 mmol) and anhydrous sodium carbonate (0.26 g, 2.5 mmol) with constant stirring. The mixture was heated to reflux temperaturesf or 48 h. The acetonitrile was evaporated under vacuum to leave abrown solid. The crude product was purified by columnc hromatography (SiO 2 ,e thyl acetate:petroleum ether, v/v =3 :7) to givet he title compound (0.16 g, 16% yield) as yellow crystals, m.p.: 452-453K. There are some differences in bond lengts and bond angles between the substituted and unsubstituted cyclopentadienyl ring [3] . The bond lengths of the substituted cyclopentadienyl ligand range from 1.428(2)-1.427(2) Å, whereas in the unsubstituted one they range from 1.388 (4) 
Discussion

